Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-073605
Filing Date
2025-05-16
Accepted
2025-05-16 16:30:25
Documents
1
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7495
  Complete submission text file 0000950170-25-073605.txt   8919
Mailing Address 6055 LUSK BLVD. SAN DIEGO CA 92121
Business Address 6055 LUSK BLVD. SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Issuer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD SAN DIEGO CA 92121
Business Address
Struthers Richard Scott (Reporting) CIK: 0001746298 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38583 | Film No.: 25959769